- The first experience with radioimmunotherapy with ibritumomab tiuxetan (Zevalin)Publication without faculty affiliation
- Radioimmunotherapy with 90Y-radiolabelled anti-CD20 Monoclan Antibody in Patients with B-cell non-Hodgkin´s Lymphoma, Nuclear Medicine as a Part of the Oncology Team2005 | Faculty of Medicine in Hradec Králové
- Radioimunotherapy ytrium-90 (90Y)-ibritumomab tiuxetanam in patients with folicular non-hodgkin lymphoma – experience of one departmen2010 | First Faculty of Medicine
- Biological drugs in hematooncology2012 | First Faculty of Medicine
- The first experience with radioimmunotherapy by 90Y-ibritumomab tiuxetan (Zevalin)Publication without faculty affiliation
- Monoclonal antibodies in the treatment of lymphomas2008 | Publication without faculty affiliation